stoxline Quote Chart Rank Option Currency Glossary
  
PetVivo Holdings, Inc. (PETV)
0.71  -0.03 (-4.05%)    02-11 15:26
Open: 0.72
High: 0.72
Volume: 3,000
  
Pre. Close: 0.74
Low: 0.71
Market Cap: 15(M)
Technical analysis
2025-02-11 4:48:33 PM
Short term     
Mid term     
Targets 6-month :  1.01 1-year :  1.14
Resists First :  0.87 Second :  0.98
Pivot price 0.75
Supports First :  0.69 Second :  0.58
MAs MA(5) :  0.74 MA(20) :  0.79
MA(100) :  0.58 MA(250) :  0.68
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  16.1 D(3) :  19.6
RSI RSI(14): 45.9
52-week High :  1.25 Low :  0.28
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PETV ] has closed above bottom band by 13.8%. Bollinger Bands are 45.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.72 - 0.73 0.73 - 0.73
Low: 0.7 - 0.7 0.7 - 0.71
Close: 0.7 - 0.71 0.71 - 0.72
Company Description

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Headline News

Tue, 11 Feb 2025
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024 - GlobeNewswire

Wed, 05 Feb 2025
PetVivo Holdings streamlines operations, COO position cut - MSN

Fri, 31 Jan 2025
PetVivo (NASDAQ:PETV) Trading Up 6% – Still a Buy? - Defense World

Mon, 27 Jan 2025
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor - GlobeNewswire

Tue, 14 Jan 2025
PetVivo to Exhibit Spryng with OsteoCushion™ Technology at - GlobeNewswire

Sat, 11 Jan 2025
New to The Street to Air Sponsored Programming on Bloomberg Television Tonight at 6:30 PM EST Featuring HPB, PillSafe, LightPath Technologies, Modular Medical, and SGTM's Sustainable Green Team - Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out -4 (M)
Shares Float 0 (M)
Held by Insiders 2e+007 (%)
Held by Institutions 1.514e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.64
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 652 %
Return on Equity (ttm) -204 %
Qtrly Rev. Growth 646.7 %
Gross Profit (p.s.) 7.46
Sales Per Share 118.42
EBITDA (p.s.) 0
Qtrly Earnings Growth -9.64e+006 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -1.11
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 129100
Forward Dividend 128080
Dividend Yield 18183100%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android